kaposi eng

Upload: sc-sc

Post on 02-Jun-2018

219 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/10/2019 Kaposi Eng

    1/36

    SMART TA

    CASE PRESENTATION

  • 8/10/2019 Kaposi Eng

    2/36

    Case presentation (1)

    A - 32 - years old man

    Thai ethnic people

    Famer in QuChu

    NghAn province

    Diagnosed with HIV: 19/07/2013

    Managed at OPC: 11/09/2013

  • 8/10/2019 Kaposi Eng

    3/36

    Case presentation(2)

    Appearance of small nodules on his chest, arms, legs

    one year ago.

    Nodules were initially light reddish purple and then

    became darker, purple, and larger (0,51cm) overtime

    No pain, no itching, no bleeding.

    Denied cough, fever, fatigue, weight loss, or night

    sweats, or blood in stool

  • 8/10/2019 Kaposi Eng

    4/36

    Past medical history and social history

    No prior ARV exposure

    No history of allergies or chronic diseases

    Relation with sex workers no protection and shared

    needle with partners 6 year ago. He stops to useheroin now

    Wife and daughter (11 year olds) are negative withHIV

    Disclosed HIV status to all family members

    Received psychological and economic supports fromfamily

  • 8/10/2019 Kaposi Eng

    5/36

    Physical examination at 11/09/2013

    Vital signs: T 36.8C, P 86 beats/min, R 18 breaths/min,

    blood pressure 110/70 mmHg. Height 164 cm, weight: 58kg

    Well appearing, no cachexia, thrush, or oral hairy

    leukoplakia

    No lymphadenopathy

    Heart: no murmurs;

    Lungs: clear

    Abdomen: no pain, no splenomegaly, no masses Neurological examinations: normal, ambulates without

    difficulty

  • 8/10/2019 Kaposi Eng

    6/36

    Skin: many purple nodules on his face, chest, arms

    without itching, pain, blanching, jaundice, or edema

  • 8/10/2019 Kaposi Eng

    7/36

    HEENT: Eyes, nose, and mouth clear but purple plaque

    noted on hard palate without bleeding

  • 8/10/2019 Kaposi Eng

    8/36

    Laboratory findings

    CD4: 178 cells/mm

    CBC:

    RBC: 5.600.000,

    Hb: 127 g/L; MCV 73 (78 - 99) WBC: 7000. N: 41,4 %; L 50,3%; mono 8,3%.

    PLT: 253 000

    HBsAg (-); Anti HCV (-)

    Chest X ray is normal

    Abdominal ultrasound was normal

  • 8/10/2019 Kaposi Eng

    9/36

    Question 1: What diseases do you think?

    1. Bacillary Angiomatosis (Bartonella Henselae)

    2. Herpes Simplex Virus (HSV)

    3. Kaposis sarcoma

    4. Leishmaniasis

  • 8/10/2019 Kaposi Eng

    10/36

    Answer (1) = Kaposi Sarcoma (KS)

    Cutaneous KS typically manifests as pigmented macules,

    plaques, papules, or nodules on skin and mucous membranes

    including face, ears, arms, torso, and legs

    Size ranges from a few millimeters to many centimeters in

    diameter and in color from red (especially in new lesions) to

    purple

    Lesions may be preceded by, or surrounded with, a yellow to

    green "halo," probably representing extravasated erythrocyte

    pigments

    In black or olive-skinned people, KS lesions may appear dark

    brown or black.

    Color of skin lesions darkens without treatment.

  • 8/10/2019 Kaposi Eng

    11/36

    Kaposis Sarcoma

  • 8/10/2019 Kaposi Eng

    12/36

    Kaposis Sarcoma

  • 8/10/2019 Kaposi Eng

    13/36

    Kaposi Sarcoma

    Kaposi sarcoma is a malignancy and was the first and most common

    AIDS-defining illness described in the U.S.

    KS can affect all organs but commonly affects the skin (95%),

    oropharynx (33%), GI tract (40%), and lungs (20-50%)

    Can also cause lymphedema (genitals, face, legs)

    Racial, genetic, and hormonal factors all have been reported to

    influence the development of KS

    The incidence of KS as an AIDS-defining illness has decreased withearly ART

  • 8/10/2019 Kaposi Eng

    14/36

    Question 2: How common are oral

    lesions with KS?

    A. 10 - 15 %

    B. 16 - 20%

    C. 20 - 25%

    D. 25 - 30%

    E. 30 - 35%

  • 8/10/2019 Kaposi Eng

    15/36

    Answer (2) = 33%

    Lesions of the oral cavity occur in about one third (33%) of patients

    with AIDS-associated KS

    Hard palate lesions are most common

    These flat, red or purple plaques, either focal or diffuse, may be

    completely asymptomatic and easily overlooked

    In other patients, however, larger nodular lesions involving the

    hard or soft palate, or both, may become exophytic and ulcerated,

    and may bleed.

    Other oral sites of KS involvement include the gingiva, tongue,

    uvula, tonsils, pharynx, and trachea. These lesions may interfere

    with eating and speaking, cause tooth loss, or compromise the

    airways.

  • 8/10/2019 Kaposi Eng

    16/36

    Question 3: What is the cure of KS?

    A. ART

    B. Valgancyclovir

    C. Foscarnet

    D. Interferon-alpha

    E. Chemotherapy

    F. Radiation treatment

  • 8/10/2019 Kaposi Eng

    17/36

    Answer (3) = No Cure for KS

    Immediate ART is first line treatment

    Chemotherapy is reserved for patients with edema, ulceration,

    extensive oral and gastrointestinal diseases, and system symptoms

    Intralesional chemotherapy, topical immune, and radiation

    treatment for local skin disease (cosmetic)

    Interferon-alpha can be used for patients with skin disease and CD4

    counts>200 cells/mm3

    Palliative care including regression of lesions, pain management,

    and symptoms related to visceral involvement is very important

  • 8/10/2019 Kaposi Eng

    18/36

    Kaposis Sarcoma

    Before and after radiation treatment

  • 8/10/2019 Kaposi Eng

    19/36

    Staging (TIS)

    (O) (1)

  • 8/10/2019 Kaposi Eng

    20/36

    Karnofsky Performance Status Score

  • 8/10/2019 Kaposi Eng

    21/36

    Management (Based on T and S)

    ART is 1stline therapy for ALL patients

    Chemotherapy based on staging

    Good prognosis is T0S0, T1S0, T0S1

    Survival >80% with effective ART

    Defer chemotherapy

    Poor prognosis is T1S1

    Survival 46-77% with effective ART

    Likely rapid progression of disease

    Immediate chemotherapy

  • 8/10/2019 Kaposi Eng

    22/36

    Question 3: What is the T and S of this

    patient?

    A. T0S0

    B. T1S0

    C. T0S1

    D. T1S1

  • 8/10/2019 Kaposi Eng

    23/36

    Answer 3: T1S0

    Management (Based on T and S): Patient: T1S0 Good

    prognosis

    Jan 24th2014 he started cotrimoxazole and immediate

    ART (TDF/3TC/FEV).

    BUT..

  • 8/10/2019 Kaposi Eng

    24/36

    Feb 13th 2014: the purple nodules on his face, chest,

    arms and in his palate appeared more and large

  • 8/10/2019 Kaposi Eng

    25/36

    Feb 13th 2014: the purple nodules on his face, chest,

    arms and in his palate appeared more and large

  • 8/10/2019 Kaposi Eng

    26/36

    Question 4: What do you think in this condition?

  • 8/10/2019 Kaposi Eng

    27/36

    f

  • 8/10/2019 Kaposi Eng

    28/36

    Histopathology: Skin biopsy report from Bach

    Mai Hospital diagnosis Kaposi Sarcoma

    Pathology typically shows marked lymphocytic

    predominance, plasma cells, angiogenesis, and spindle cells

    infiltrating collagen like schools of fish

    i h i i i d i h

  • 8/10/2019 Kaposi Eng

    29/36

    Question 5: What virus is associated with

    Kaposi sarcoma?

    A) Human papilomavirus (HPV)

    B) Human herpesvirus 8 (HHV8)

    C) Epstein-Barr virus (EBV)

    E) Herpes Simplex 2 Virus (HSV-2)

  • 8/10/2019 Kaposi Eng

    30/36

    Answer (5)

    Human papilomavirus: persitent infection with high risk of

    Human papilomavirus (HPV) is associated with development of

    cervical cancer

    EBV also associated with number of malignancies: B and T cell

    lymphomas, Hodgkins disease, leimyosarcoma andnosopharyngeal carcinoma. These cancers show a increased

    frequency in patients with immunodeficiency.

    Herpes simplex viruses:

    - herpes type 1: oral herpes

    - herpes type 2: genital

  • 8/10/2019 Kaposi Eng

    31/36

    Answer (5) = HHV8

    There are four types of KS

    Classic (old men of Meditarrean descent)

    Endemic (young and old in sub-saharan Africa)

    Transplant associated (due to immune suppression)

    AIDS associated (90% of cases in MSM in west)

    HHV8 associated with all four types

    HHV8 produces factors and cytokines that results in angiogenesis,

    collagen proliferation, and blocking of apoptosis (cell triggered

    death)

    Cannot eradicate from body

  • 8/10/2019 Kaposi Eng

    32/36

    Question 6: How is HHV- 8 most

    commonly transmitted ?

    1) Breast Milk

    2) Semen

    3) Pregnancy

    4) Transplanted organs

    5) Saliva

    6) Along with sexual transmitted diseases

  • 8/10/2019 Kaposi Eng

    33/36

    Answer (6) = Saliva

    Saliva is most common mode of transmission

    HHV 8 shed in saliva among immunocompetent and compromised

    persons

    Can be spread by all other means as well Contributing factor among MSM who may engage in high

    frequency oral and oral-anal sex

    Some evidence that transmission linked with Gonorrhea

    Low rates of HHV-8 and associated KS in Southeast Asia mayreflect predominantly injection use epidemic

  • 8/10/2019 Kaposi Eng

    34/36

    Case Progression

    Good ART adherence

    Gain weight from 58 kg to 60kg

    Normal working

    No more OIs Number of lesions reduced and slighter, some skin lesions

    disappeared

    4 /9/2014:

    - CD4: 440 cells/mm- CBC, ALT, creatinine: normal

  • 8/10/2019 Kaposi Eng

    35/36

    Conclusions

    Kaposi's sarcoma is a malignant tumor associated with HHV-8

    It primarily affects skin but may also affect mucosal linings, in

    particularly the GI tract as well as the lungs

    KS exists in Vietnam and will likely increase with rise in MSMepidemic

    Diagnosis of KS is primarily clinical with follow-up biopsy and

    histopathology as needed

    First line treatment is immediate ART for all cases Chemotherapy is reserved for severe cases

    There is no cure for KS

  • 8/10/2019 Kaposi Eng

    36/36

    THANK YOU